Stefania Cuzzubbo

11PUBLICATIONS
49CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 01, 2026
Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Jun 01, 2023
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.

Patrick R Benusiglio, Fikret Elder, Mehdi Touat

|Dec 11, 2022
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy.

Stefania Cuzzubbo, Benoit Roch, Guillaume Darrasse-Jèze

|Jul 19, 2022
Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.

Renata Ursu, Didier Maillet, Catherine Belin

|Apr 03, 2021
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances.

Stefania Cuzzubbo, Antoine F Carpentier

Pageof 2

Frequent Collaborators

5 joint publications

Antoine F Carpentier

2 joint publications

Caroline Dehais

2 joint publications

Agusti Alentorn

2 joint publications

Ahmed Idbaih